Marissa Howard is a postdoctoral researcher at George Mason University, renowned for her groundbreaking work in cellular communication and cancer treatment. Howard holds a PhD in Biosciences and a BS in Bioengineering from Mason. She leads a team at the Center for Applied Proteomics and Molecular Medicine (CAPMM) that has pioneered a method to "eavesdrop" on cellular communications, offering revolutionary potential for cancer therapy. Her research, focused on extracellular vesicles, has garnered significant attention, including a $200k National Cancer Institute grant. Howard's work extends beyond cancer, with implications for various diseases such as Alzheimer’s and Parkinson’s.